drugset / Trial / NCT00407264

Randomized Trial of Fluticasone in Bronchial Premalignancy

NCT00407264

RandomizedCrossoverDouble-blindPrevention

Summary

The purpose of this study is to assess the efficacy of fluticasone on the development of lung cancer in smokers

Timeline

Start
2002-02
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 500 ug Inhaled